HomeCompareJNJ vs NOW

JNJ vs NOW: Dividend Comparison 2026

JNJ yields 2.14% · NOW yields 1.91%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $8.0K in total portfolio value· pulled ahead in Year 7
10 years
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →
NOW
NOW
● Live price
1.91%
Share price
$104.97
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.5K
Annual income
$215.52
Full NOW calculator →

Portfolio growth — JNJ vs NOW

📍 JNJ pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJNJNOW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JNJ + NOW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JNJ pays
NOW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
NOW
Annual income on $10K today (after 15% tax)
$161.95/yr
After 10yr DRIP, annual income (after tax)
$183.19/yr
At 15% tax rate, JNJ beats the other by $3,854.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JNJ + NOW for your $10,000?

JNJ: 50%NOW: 50%
100% NOW50/50100% JNJ
Portfolio after 10yr
$26.5K
Annual income
$2,482.70/yr
Blended yield
9.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NOW right now

JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
NOW
Analyst Ratings
58
Buy
8
Hold
1
Sell
Consensus: Buy
Price Target
$196.29
+87.0% upside vs current
Range: $115.00 — $263.00
Altman Z
6.1
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JNJ buys
8
NOW buys
14
PoliticianChamberTickerTypeAmountDate
Charles J. "Chuck" Fleischmann🏢 House$NOW▲ Buy$1,001 - $15,0002026-02-20
Byron Donalds🏢 House$NOW▲ Buy$1,001 - $15,0002026-02-10
Byron Donalds🏢 House$NOW▲ Buy$1,001 - $15,0002026-02-10
Tony Wied🏢 House$NOW▲ Buy$15,001 - $50,0002026-02-04
Josh Gottheimer🏢 House$NOW▼ Sell$1,001 - $15,0002026-01-30
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Markwayne Mullin🏛 Senate$NOW▲ Buy$15,001 - $50,0002025-12-29
Markwayne Mullin🏛 Senate$NOW▲ Buy$15,001 - $50,0002025-12-29
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Josh Gottheimer🏢 House$NOW▼ Sell$1,001 - $15,0002025-12-17
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJNJNOW
Forward yield2.14%1.91%
Annual dividend / share$5.20$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR28%0%
Portfolio after 10y$30.5K$22.5K
Annual income after 10y$4,749.88$215.52
Total dividends collected$15.6K$2.0K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyBuy
Analyst price target$228.73$196.29

Year-by-year: JNJ vs NOW ($10,000, DRIP)

YearJNJ PortfolioJNJ Income/yrNOW PortfolioNOW Income/yrGap
1$10,594$274.49$10,891$190.53$297.00NOW
2$11,294$360.69$11,847$193.92$553.00NOW
3$12,133$476.91$12,873$197.15$740.00NOW
4$13,156$635.42$13,975$200.22$819.00NOW
5$14,432$854.61$15,156$203.13$724.00NOW
6$16,056$1,162.76$16,423$205.89$367.00NOW
7← crossover$18,175$1,604.53$17,781$208.50+$394.00JNJ
8$21,009$2,252.68$19,236$210.97+$1.8KJNJ
9$24,911$3,229.73$20,796$213.31+$4.1KJNJ
10$30,458$4,749.88$22,468$215.52+$8.0KJNJ

JNJ vs NOW: Complete Analysis 2026

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

NOWStock

ServiceNow, Inc. provides enterprise cloud computing solutions that defines, structures, consolidates, manages, and automates services for enterprises worldwide. It operates the Now platform for workflow automation, artificial intelligence, machine learning, robotic process automation, performance analytics, electronic service catalogs and portals, configuration management systems, data benchmarking, encryption, and collaboration and development tools. The company also provides information technology (IT) service management applications; IT service management product suite for enterprise's employees, customers, and partners; IT business management product suite; IT operations management product that connects a customer's physical and cloud-based IT infrastructure; IT Asset Management to automate IT asset lifecycles; and security operations that connects with internal and third party. In addition, it offers governance, risk, and compliance product to manage risk and resilience; human resources, legal, and workplace service delivery products; safe workplace applications; customer service management product; and field service management applications. Further, it provides App Engine product; IntegrationHub enables application to extend workflows; and professional, industry solutions, and customer support services. It serves government, financial services, healthcare, telecommunications, manufacturing, IT services, technology, oil and gas, education, and consumer products through direct sales team and resale partners. It has a strategic partnership with Celonis to help customers identify and prioritize processes that are suitable for automation. The company was formerly known as Service-now.com and changed its name to ServiceNow, Inc. in May 2012. The company was founded in 2004 and is headquartered in Santa Clara, California.

Full NOW Calculator →
📬

Get this JNJ vs NOW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JNJ vs ABBVJNJ vs MRKJNJ vs PFEJNJ vs BMYJNJ vs LLYJNJ vs SCHDJNJ vs JEPIJNJ vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.